Safety, tolerability, and activity of the active C1s antibody riliprubart in cold agglutinin disease: a phase 1b study
- Resource Type
- Article
- Source
- In
Blood 22 February 2024 143(8):713-720 - Subject
Clinical Trials and Observations Red Cells, Iron, and Erythropoiesis Free Research Articles - Language
- ISSN
- 0006-4971